ArticleInternational journal of retina and vitreous2025
Artificial intelligence, data sharing, and privacy for retinal imaging under Brazilian Data Protection Law.
Article in International journal of retina and vitreous, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Review
- Artificial intelligence in retinal care: transforming the doctor-patient partnership.International journal of retina and vitreous · 2026Review
- Artificial intelligence-based apps for screening and diagnosing diabetic retinopathy and common ocular disorders.World journal of methodology · 2025Review
- Artificial Intelligence in Diabetic Retinopathy and Diabetic Macular Edema: A Narrative Review.Bioengineering (Basel, Switzerland) · 2025Review
- Applying artificial intelligence to cardiac MRI to diagnose congenital heart disease in low-resource settings such as Sub-Saharan Africa.Communications medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The integration of artificial intelligence (AI) in healthcare has revolutionized various medical domains, including radiology, intensive care, and ophthalmology. However, the increasing reliance on AI-driven systems raises concerns about bias, particularly when models are trained on non-representative data, leading to skewed outcomes that disproportionately affect minority groups. Addressing bias is essential for ensuring equitable healthcare, necessitating the development and validation of AI models within specific populations. This viewpoint paper explores the critical role of data in AI development, emphasizing the importance of creating representative datasets to mitigate disparities. It discusses the challenges of data bias, the need for local validation of AI algorithms, and the misconceptions surrounding retinal imaging in ophthalmology. Additionally, highlights the significance of publicly available datasets in research and education, particularly the underrepresentation of low- and middle-income countries in such datasets. The Brazilian General Data Protection Law is also examined, focusing on its implications for research and data sharing, including the legal and ethical measures required to safeguard data integrity and privacy. Finally, the manuscript underscores the importance of adhering to the FAIR principles (Findability, Accessibility, Interoperability, and Reusability) to enhance data usability and support responsible AI development in healthcare.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.